deCODE genetics (Nasdaq:DCGN) today announced that it will host live webcasts
of its presentations at two upcoming investor conferences, the BioCentury Newsmakers
in the Biotech Industry Conference and the Thomas Weisel Partners Healthcare
Conference. Both conferences will be held on September 7. deCODE management
will present at the BioCentury conference at 4pm ET/8pm GMT, at the Millennium
Broadway Hotel in New York, and at the Thomas Weisel conference at 4:25pm EDT/8:25
GMT, at the Four Seasons hotel in Boston.
The webcasts can be accessed through the Investors
page on deCODE’s website,
www.decode.com. Those interested in listening should log on a few minutes in
advance in order to download any software or complete any sign-in that may
be required.
About deCODE
deCODE genetics (NASDAQ:DCGN) is a global leader in applying human genetics
to develop drugs for common diseases. Our population approach has enabled
us to discover and target key biological pathways involved in conditions
ranging from heart attack to cancer. We are turning these discoveries into
new medicine to better treat and prevent many of the biggest challenges to
public health. deCODE is delivering on the promise of the new genetics.SM
Visit us on the web at www.decode.com.
